We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+10.56%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$12.2B
AUM Growth
+$1.03B
Cap. Flow
+$49.2M
Cap. Flow %
0.4%
Top 10 Hldgs %
25.44%
Holding
2,628
New
63
Increased
565
Reduced
814
Closed
130

Top Buys

Rank Stock Value
1
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$379M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$14.1M
3
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$12.6M
4
EPAM icon
EPAM Systems
EPAM
+$8.07M
5
AA icon
Alcoa
AA
+$4.54M

Top Sells

Rank Stock Value
1
EPD icon
Enterprise Products Partners
EPD
+$31.9M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$31.2M
3
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$28.5M
4
MMP
Magellan Midstream Partners, L.P.
MMP
+$20.9M
5
AAPL icon
Apple
AAPL
+$14.5M

Sector Composition

Rank Sector Weight
1 Technology 22.34%
2 Healthcare 12.24%
3 Financials 12%
4 Consumer Discretionary 11.44%
5 Industrials 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATOS icon
2501
Atossa Therapeutics
ATOS
$23.5M
– –
-1,328
Closed -$64.9K
BASE
2502
DELISTED
Couchbase
BASE
– –
-4,038
Closed -$126K
BEEM icon
2503
Beam Global
BEEM
$25.8M
– –
-3,199
Closed -$87.6K
BOLT icon
2504
Bolt Biotherapeutics
BOLT
$6.63M
– –
-476
Closed -$120K
BYSI icon
2505
BeyondSpring
BYSI
$30.5M
– –
-8,173
Closed -$129K
CLPT icon
2506
ClearPoint Neuro
CLPT
$463M
– –
-7,721
Closed -$137K
CRDF icon
2507
Cardiff Oncology
CRDF
$77.1M
– –
-14,624
Closed -$97.4K
CTSO icon
2508
Cytosorbents Corp
CTSO
$23.3M
– –
-15,424
Closed -$125K
CURI icon
2509
CuriosityStream
CURI
$166M
– –
-4,891
Closed -$51.6K
CURV icon
2510
Torrid Holdings
CURV
$228M
– –
-5,758
Closed -$88.8K
DAWN
2511
DELISTED
Day One Biopharmaceuticals
DAWN
– –
-4,806
Closed -$114K
DRRX
2512
DELISTED
DURECT Corp
DRRX
– –
-8,618
Closed -$110K
DSGR icon
2513
Distribution Solutions Group
DSGR
$1.61B
– –
-3,488
Closed -$87.2K
ELTX icon
2514
Elicio Therapeutics
ELTX
$80.4M
– –
-981
Closed -$95.8K
ENB icon
2515
Enbridge
ENB
$112B
– –
-343,563
Closed -$13.7M
EOLS icon
2516
Evolus
EOLS
$536M
– –
-2,791
Closed -$21.3K
EPD icon
2517
Enterprise Products Partners
EPD
$81.9B
– –
-1,474,535
Closed -$31.9M
ERNA icon
2518
Eterna Therapeutics
ERNA
$5.16M
– –
-1
Closed -$100K
ESPR
2519
DELISTED
Esperion Therapeutics
ESPR
– –
-5,894
Closed -$71K
ET icon
2520
Energy Transfer Partners
ET
$72.1B
– –
-1
Closed -$10
GLUE icon
2521
Monte Rosa Therapeutics
GLUE
$1.36B
– –
-4,756
Closed -$106K
GWRS icon
2522
Global Water Resources
GWRS
$219M
– –
-4,489
Closed -$84K
IBIO icon
2523
iBio
IBIO
$73M
– –
-166
Closed -$88.2K
IMRX icon
2524
Immuneering
IMRX
$328M
– –
-3,719
Closed -$98.7K
INNV icon
2525
InnovAge Holding
INNV
$1.42B
– –
-8,476
Closed -$56K
99 100
101
102 103

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

MetLife Investment Management's Q4 2021 Portfolio in Review

As of Q4 2021, MetLife Investment Management held 2,628 positions worth $12.2B, up 9.2% from $11.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management's Q4 2021 filing shows 63 new, 565 increased, 814 reduced and 130 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,855,000 shares worth $378M. The largest sale was Enterprise Products Partners, an estimated $31.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q4 2021 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,855,000 shares worth $378M.
  • MetLife Investment Management added most to iShares Russell 2000 ETF in Q4 2021, an estimated $14.1M increase.
  • MetLife Investment Management's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $31.2M.
  • MetLife Investment Management fully exited Enterprise Products Partners in Q4 2021, selling an estimated $31.9M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $12.2B portfolio in Q4 2021.
  • MetLife Investment Management opened 63 new positions and closed 130 in Q4 2021.
  • MetLife Investment Management's portfolio value rose 9.2% quarter-over-quarter to $12.2B.

Based on MetLife Investment Management's 13F filing for Q4 2021, filed 15 Feb 2022.